The slight increase in thrombin-antithrombin complex, elevated fibrinogen degradation products, and platelet decrease in the presence of bleeding complications also suggested a bleeding tendency due to disseminated intravascular coagulation, but the rise in plasmin-α2 plasmin inhibitor complex (PIC) was slight, so it was not considered. This evidence concerns the gene PLG and Disseminated intravascular coagulation.